Tolvaptan drug levels measured in healthy volunteers
NCT ID NCT07166796
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-phase trial studied how the drug Tolvaptan is processed in the body. 64 healthy men received either a single dose or multiple doses of Tolvaptan. Researchers measured drug levels in the blood to understand its pharmacokinetics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tolvaptan
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.